Potent and selective inhibitors of the Abl-kinase: phenylamino-pyrimidine (PAP) derivatives
- 1 January 1997
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 7 (2) , 187-192
- https://doi.org/10.1016/s0960-894x(96)00601-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cellsNature Medicine, 1996
- Patent Update: Oncologic, Endocrine & Metabolic Small molecule inhibitors of tyrosine kinase activityExpert Opinion on Therapeutic Patents, 1995
- Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity induces K562 to differentiateBlood, 1993
- Preparation of substituted N-phenyl-4-aryl-2-pyrimidinamines as mediator release inhibitorsJournal of Medicinal Chemistry, 1993
- Tyrphostins: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transductionThe FASEB Journal, 1992
- Selective Inhibition of Leukemia Cell Proliferation by BCR-ABL Antisense OligodeoxynucleotidesScience, 1991
- Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene ProductsScience, 1990
- Acute leukaemia in bcr/abl transgenic miceNature, 1990
- Molecular Pathogenesis of Ph-Positive LeukemiasAnnual Review of Medicine, 1989